Accedi

Bibliografie tematiche / HCV / Libri

Libri sul tema "HCV"

Segui questo link per vedere altri tipi di pubblicazioni sul tema: HCV.

Autore: Grafiati

Pubblicato: 4 giugno 2021

Ultima modifica: 6 settembre 2023

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 libri per l'attività di ricerca sul tema "HCV".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi i libri di molte aree scientifiche e compila una bibliografia corretta.

1

Thiemann, Lillian. Double jeopardy: The HIV/HCV co-infection handbook. New York: Community Prescription Service, 1999.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Dammacco, Franco, a cura di. HCV Infection and Cryoglobulinemia. Milano: Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-1705-4.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Dammacco, Franco. HCV Infection and Cryoglobulinemia. Milano: Springer-Verlag Italia, 2012.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Musharraf, Husain, e Population Council (Bangladesh), a cura di. Prevalence of HIV, HBV, HCV and syphilis markers in pregnant women of Bangladesh. Dhaka, Bangladesh: Population Council, 1997.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Okita, Kiwamu, a cura di. HCV and Related Liver Diseases. Tokyo: Springer Japan, 1999. http://dx.doi.org/10.1007/978-4-431-68488-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Jürgens, Ralf. HIV/AIDS and HCV in prisons: A select annotated bibliography. Ottawa, Ont: International Affairs Directorate, Health Canada, 2005.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Okita, Kiwamu, a cura di. HCV/Oxidative Stress and Liver Disease. Tokyo: Springer Japan, 2003. http://dx.doi.org/10.1007/978-4-431-67005-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Kiwamu, Okita, a cura di. HCV/oxidative stress and liver disease. Tokyo: Springer, 2003.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

name, No. HCV/oxidative stress and liver disease. Tokyo: Springer, 2003.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Sofia, Michael J., a cura di. HCV: The Journey from Discovery to a Cure. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-28400-8.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

11

Sofia, Michael J., a cura di. HCV: The Journey from Discovery to a Cure. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-28207-3.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

12

Dirgahayu, Paramasari. Molecular epidemiology database of HIV, HBV, HCV, HDV, HTLV-1/2, and TTV in Central of Java, Indonesia: Final report international research collaboration and international publication. [Surakarta]: Sebelas Maret Univ., 2010.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

13

Association, Canadian Hospital, a cura di. Guide to policies for health care facilities and agencies: Bloodborne pathogens, especially Human Immunodeficiency Virus (HIV), Hepatitis B Virus, (HBV) and Hepatitis C Virus (HCV). Ottawa, Ont: Canadian Hospital Association, 1994.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

14

G, Gish Robert, a cura di. Maximizing the benefits of antiviral therapy for HCV: The advantages of treating side effects. Philadelphia: W.B. Saunders, 2004.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

15

Duncan, Tim. Conquering Hepatitis C and surviving treatment: An essential guide through every step of the HCV treatment process. [Place of publication not identified]: T. Duncan, 2010.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

16

Giulio, Pisani, a cura di. Nucleic acid amplification technology (NAT) for the detection of Hepatitis C Virus (HCV) in plasma pools: Validation report. Roma: Istituto superiore di sanità, 2000.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

17

Mohamed Hatem Fathi El-Saied Wali. Natural history, factors affecting severity and progression rate of hepatitis c virus (HCV) infection in liver transplanted and non-transplanted patients. Birmingham: University of Birmingham, 2002.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

18

Seminario, di aggiornamento sull'epatite da HCV: diagnosi epidemiologia prevenzione e. terapia (4th 1997 Rome Italy). IV Seminario di aggiornamento sull'epatite da HCV: Diagnosi, epidemiologia, prevenzione e terapia : Istituto superiore di sanità, Roma, 3-4 novembre 1997 : atti. Roma: Istituto superiore di sanità, 1997.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

19

Käser, Elke Beatrice. Der Hallesche HCV-Impfschadensfall 1978/79 und die Verantwortung der Bundesrepublik Deutschland: Gleichzeitig ein Beitrag zu intertemporalkollisionsrechtlichen Fragestellungen auf einfachgesetzlicher und verfassungsrechtlicher Ebene. Leipzig: Leipziger Universitätsverlag, 1999.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

20

Seminario, di aggiornamento sull'epatite da virus HCV e. nuovi virus potenzialmente epatitici: diagnosi epidemiologia prevenzione e. terapia (5th 2000 Rome Italy). V Seminario di aggiornamento sull'epatite da virus HCV e nuovi virus potenzialmente epatitici: Diagnosi, epidemiologia, prevenzione e terapia : Istituto superiore di sanità, Roma, 20-21 dicembre 2000 : atti. Roma: Istituto superiore di sanità, 2000.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

21

Corporation, International Business Machines, a cura di. I/O configuration using z/OS HCD and HCM. [S.l.]: Vervante, 2010.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

22

Administration, United States Occupational Safety and Health. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Washington, D.C: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1990.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

23

United States. Occupational Safety and Health Administration. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Washington, D.C: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1990.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

24

United States. Occupational Safety and Health Administration. Enforcement procedures for occupational exposure to Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV). [Washington, D.C.?: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1988.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

25

Kumar, Rajendra. HCI Human Computer Interaction: HCI. 2^a ed. India: Laxmi Publications, 2005.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

26

Wilson, Deanna. Hepatitis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0035.

Testo completo

Abstract (sommario):

Hepatitis A (HAV) and E (HEV) viruses are spread via the fecal-oral route. Hepatitis B virus (HBV) exposure is via occupational or recreational activities. Hepatitis D virus (HDV; also spread parentally) can only coinfect or superinfect those with chronic HBV. Hepatitis C (HCV) transmission is predominantly parenteral; the highest risk group is injection drug users. Prodromal-period patients with acute hepatitis present with vague constitutional symptoms when serum transaminases peak, with elevated serum bilirubin and varying levels of hepatic protein synthesis impairment; during the icteric phase, patients develop abdominal pain, hepatomegaly, and jaundice. Acute hepatitis has limited therapy; treatment is predominantly supportive. However, most adults with acute phase HAV, HBV, HDV, and HEV spontaneously clear the virus. Most individuals with HCV develop chronic hepatitis. Patients with known HAV, HBV, or HEV exposures may be eligible for post-exposure prophylaxis to reduce their risk of infection.

Gli stili APA, Harvard, Vancouver, ISO e altri

27

Keshav, Satish, e Palak Trivedi. Viral hepatitis. A cura di Patrick Davey e David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0212.

Testo completo

Abstract (sommario):

Hepatitis means ‘inflammation of the liver’ and is manifest with symptoms that include malaise, anorexia, fever, flu-like symptoms, and pain in the right upper quadrant of the abdomen, with the pain being caused by swelling of the liver and its capsule. Elevations in circulating hepatic enzymes, particularly aspartate transaminase and alanine transaminase, are common, with jaundice occurring some time after the onset of other symptoms and signs. There are five viruses that primarily cause viral hepatitis: hepatitis A, B, C, D, and E viruses, abbreviated HAV, HBV, HCV, HDV, and HEV, respectively. These viruses are all hepatotrophic, in that the liver is the primary site of infection. HAV, HBV, and HEV are usually acute, self-limiting infections that may, nonetheless, cause morbidity and, in the case of HEV, fatality. However, HBV and, more so, HCV can cause chronic carriage of the virus over many years, as well as the development of chronic hepatitis. HDV is only pathogenic in conjunction with HBV. After recovery from acute infection with HAV, individuals have long-lasting immunity against further infection. The same holds true for the majority of individuals with acute HBV infection. There seems to be little natural immunity to HCV infection, and a significant proportion of cases result in chronic hepatitis. Immunity to HEV is not long-lasting, and repeated infections are possible. Many other viruses can cause hepatitis, of which cytomegalovirus, herpes simplex virus, Epstein–Barr virus, and flaviviruses such as dengue and yellow fever are the most important. The liver, however, is not their primary site of replication or cellular damage.

Gli stili APA, Harvard, Vancouver, ISO e altri

28

HCV Testing. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2013.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

29

Decision-Making in HIV/HCV Co-Infection. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2016.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

30

Price, Jennifer Cohen, Priyanka Amin e Antoine Douaihy. Hepatitis C and HIV Co-Infection. A cura di Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding e Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0043.

Testo completo

Abstract (sommario):

Chronic infection with hepatitis C virus (HCV) is a leading cause of end-stage liver disease and is the most common indication for liver transplantation in the United States. Because of shared risk factors, individuals living with HIV infection are disproportionately affected by HCV. Moreover, co-infection with HIV accelerates the natural history of chronic HCV infection, increasing the risk of cirrhosis, hepatocellular carcinoma, hepatic decompensation, and death. Highly effective medications such as direct-acting antivirals (DAA) to cure HCV are now available and have the potential to profoundly improve the health of HIV-HCV-co-infected individuals. However, addressing the many gaps in the HCV care cascade is necessary to fully achieve the benefits of these drugs. This chapter reviews the natural history of HIV-HCV co-infection, the psychiatric comorbidities associated with HCV infection, the evolution of HCV treatment, and the barriers to care that HIV-HCV-co-infected individuals continue to face.

Gli stili APA, Harvard, Vancouver, ISO e altri

31

Ashm. Decision Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2016.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

32

Preventing HCV in Scotland. NHS Health Scotland, 2002.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

33

Decision Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

34

Dammacco, Franco. HCV Infection and Cryoglobulinemia. Springer, 2014.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

35

Decision Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2015.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

36

Decision Making in Hcv. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

37

Decision-Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

38

HIV, STIs, HEPATITIS B (HBV) and HEPATITIS C (HCV) ISSUES for MEDICARE LOCALS. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

39

Decision Making in HCV (Canada). Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

40

HCV and Related Liver Diseases. Springer, 2012.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

41

Okita, Kiwamu. HCV and Related Liver Diseases. Springer London, Limited, 2012.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

42

Hcv Treatments Quick Reference Tool. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

43

Decision-Making in Hcv ¿ Portugal. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2018.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

44

Okita, Kiwamu. HCV and Related Liver Diseases. Springer, 2012.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

45

HCV Treatment Quick Reference Tool. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2017.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

46

Hsieh, Meng-Tien. HBV- and HCV-related hepatocarcinogenesis: Mechanisms and implication of treatment. 2005.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

47

Decision-Making in Hcv in Chicago. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2018.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

48

Okita, K. HCV/Oxidative Stress and Liver Disease. Springer London, Limited, 2013.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

49

HCV TREATMENTS QUICK REFERENCE TOOL (Canada). Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

50

Okita, K. Hcv/Oxidative Stress and Liver Disease. Springer, 2013.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!